Close Menu
Home › Foundation Medicine Q4 Revenues Grow 11 Percent

Foundation Medicine Q4 Revenues Grow 11 Percent

Feb 22, 2017
|
staff reporter

This article has been updated with information and comments from Foundation Medicine's earning call.

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that its fourth quarter revenues climbed 11 percent, driven by strong growth from its biopharmaceutical business.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Qiagen Says It Is Fielding Acquisition Offers

  2. Cancer Diagnostics Firm Lucence Raises $20M

  3. Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

  4. Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear

    Premium

  5. T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.